Global Phage Therapy Market Insights and Forecast to 2028

Report ID: 1228029 | Published Date: Jan 2025 | No. of Page: 129 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Phage Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 DsDNA Bacteriophage
        1.2.3 SsDNA Bacteriophage
        1.2.4 SsRNA Bacteriophage
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Phage Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Animal Health
        1.3.3 Aquaculture
        1.3.4 Agriculture
        1.3.5 Food Industry
        1.3.6 Human Health
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Phage Therapy Market Perspective (2017-2028)
    2.2 Phage Therapy Growth Trends by Region
        2.2.1 Phage Therapy Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Phage Therapy Historic Market Size by Region (2017-2022)
        2.2.3 Phage Therapy Forecasted Market Size by Region (2023-2028)
    2.3 Phage Therapy Market Dynamics
        2.3.1 Phage Therapy Industry Trends
        2.3.2 Phage Therapy Market Drivers
        2.3.3 Phage Therapy Market Challenges
        2.3.4 Phage Therapy Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Phage Therapy Players by Revenue
        3.1.1 Global Top Phage Therapy Players by Revenue (2017-2022)
        3.1.2 Global Phage Therapy Revenue Market Share by Players (2017-2022)
    3.2 Global Phage Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Phage Therapy Revenue
    3.4 Global Phage Therapy Market Concentration Ratio
        3.4.1 Global Phage Therapy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Phage Therapy Revenue in 2021
    3.5 Phage Therapy Key Players Head office and Area Served
    3.6 Key Players Phage Therapy Product Solution and Service
    3.7 Date of Enter into Phage Therapy Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Phage Therapy Breakdown Data by Type
    4.1 Global Phage Therapy Historic Market Size by Type (2017-2022)
    4.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028)
5 Phage Therapy Breakdown Data by Application
    5.1 Global Phage Therapy Historic Market Size by Application (2017-2022)
    5.2 Global Phage Therapy Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Phage Therapy Market Size (2017-2028)
    6.2 North America Phage Therapy Market Size by Type
        6.2.1 North America Phage Therapy Market Size by Type (2017-2022)
        6.2.2 North America Phage Therapy Market Size by Type (2023-2028)
        6.2.3 North America Phage Therapy Market Share by Type (2017-2028)
    6.3 North America Phage Therapy Market Size by Application
        6.3.1 North America Phage Therapy Market Size by Application (2017-2022)
        6.3.2 North America Phage Therapy Market Size by Application (2023-2028)
        6.3.3 North America Phage Therapy Market Share by Application (2017-2028)
    6.4 North America Phage Therapy Market Size by Country
        6.4.1 North America Phage Therapy Market Size by Country (2017-2022)
        6.4.2 North America Phage Therapy Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Phage Therapy Market Size (2017-2028)
    7.2 Europe Phage Therapy Market Size by Type
        7.2.1 Europe Phage Therapy Market Size by Type (2017-2022)
        7.2.2 Europe Phage Therapy Market Size by Type (2023-2028)
        7.2.3 Europe Phage Therapy Market Share by Type (2017-2028)
    7.3 Europe Phage Therapy Market Size by Application
        7.3.1 Europe Phage Therapy Market Size by Application (2017-2022)
        7.3.2 Europe Phage Therapy Market Size by Application (2023-2028)
        7.3.3 Europe Phage Therapy Market Share by Application (2017-2028)
    7.4 Europe Phage Therapy Market Size by Country
        7.4.1 Europe Phage Therapy Market Size by Country (2017-2022)
        7.4.2 Europe Phage Therapy Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Phage Therapy Market Size (2017-2028)
    8.2 Asia-Pacific Phage Therapy Market Size by Type
        8.2.1 Asia-Pacific Phage Therapy Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Phage Therapy Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Phage Therapy Market Share by Type (2017-2028)
    8.3 Asia-Pacific Phage Therapy Market Size by Application
        8.3.1 Asia-Pacific Phage Therapy Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Phage Therapy Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Phage Therapy Market Share by Application (2017-2028)
    8.4 Asia-Pacific Phage Therapy Market Size by Region
        8.4.1 Asia-Pacific Phage Therapy Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Phage Therapy Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Phage Therapy Market Size (2017-2028)
    9.2 Latin America Phage Therapy Market Size by Type
        9.2.1 Latin America Phage Therapy Market Size by Type (2017-2022)
        9.2.2 Latin America Phage Therapy Market Size by Type (2023-2028)
        9.2.3 Latin America Phage Therapy Market Share by Type (2017-2028)
    9.3 Latin America Phage Therapy Market Size by Application
        9.3.1 Latin America Phage Therapy Market Size by Application (2017-2022)
        9.3.2 Latin America Phage Therapy Market Size by Application (2023-2028)
        9.3.3 Latin America Phage Therapy Market Share by Application (2017-2028)
    9.4 Latin America Phage Therapy Market Size by Country
        9.4.1 Latin America Phage Therapy Market Size by Country (2017-2022)
        9.4.2 Latin America Phage Therapy Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Phage Therapy Market Size (2017-2028)
    10.2 Middle East & Africa Phage Therapy Market Size by Type
        10.2.1 Middle East & Africa Phage Therapy Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Phage Therapy Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Phage Therapy Market Share by Type (2017-2028)
    10.3 Middle East & Africa Phage Therapy Market Size by Application
        10.3.1 Middle East & Africa Phage Therapy Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Phage Therapy Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Phage Therapy Market Share by Application (2017-2028)
    10.4 Middle East & Africa Phage Therapy Market Size by Country
        10.4.1 Middle East & Africa Phage Therapy Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Phage Therapy Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 NPO Microgen
        11.1.1 NPO Microgen Company Details
        11.1.2 NPO Microgen Business Overview
        11.1.3 NPO Microgen Phage Therapy Introduction
        11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022)
        11.1.5 NPO Microgen Recent Developments
    11.2 Proteon Pharmaceuticals
        11.2.1 Proteon Pharmaceuticals Company Details
        11.2.2 Proteon Pharmaceuticals Business Overview
        11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction
        11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022)
        11.2.5 Proteon Pharmaceuticals Recent Developments
    11.3 Phagelux
        11.3.1 Phagelux Company Details
        11.3.2 Phagelux Business Overview
        11.3.3 Phagelux Phage Therapy Introduction
        11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022)
        11.3.5 Phagelux Recent Developments
    11.4 Intralytix
        11.4.1 Intralytix Company Details
        11.4.2 Intralytix Business Overview
        11.4.3 Intralytix Phage Therapy Introduction
        11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022)
        11.4.5 Intralytix Recent Developments
    11.5 Micreos
        11.5.1 Micreos Company Details
        11.5.2 Micreos Business Overview
        11.5.3 Micreos Phage Therapy Introduction
        11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022)
        11.5.5 Micreos Recent Developments
    11.6 Eliava BioPreparations
        11.6.1 Eliava BioPreparations Company Details
        11.6.2 Eliava BioPreparations Business Overview
        11.6.3 Eliava BioPreparations Phage Therapy Introduction
        11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022)
        11.6.5 Eliava BioPreparations Recent Developments
    11.7 Locus Biosciences,Inc
        11.7.1 Locus Biosciences,Inc Company Details
        11.7.2 Locus Biosciences,Inc Business Overview
        11.7.3 Locus Biosciences,Inc Phage Therapy Introduction
        11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022)
        11.7.5 Locus Biosciences,Inc Recent Developments
    11.8 Pharmex Group,LLC
        11.8.1 Pharmex Group,LLC Company Details
        11.8.2 Pharmex Group,LLC Business Overview
        11.8.3 Pharmex Group,LLC Phage Therapy Introduction
        11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022)
        11.8.5 Pharmex Group,LLC Recent Developments
    11.9 Pherecydes Pharma
        11.9.1 Pherecydes Pharma Company Details
        11.9.2 Pherecydes Pharma Business Overview
        11.9.3 Pherecydes Pharma Phage Therapy Introduction
        11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022)
        11.9.5 Pherecydes Pharma Recent Developments
    11.10 APS Biocontrol Ltd. (APS)
        11.10.1 APS Biocontrol Ltd. (APS) Company Details
        11.10.2 APS Biocontrol Ltd. (APS) Business Overview
        11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction
        11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022)
        11.10.5 APS Biocontrol Ltd. (APS) Recent Developments
    11.11 Qingdao Phagepharm Bio-tech
        11.11.1 Qingdao Phagepharm Bio-tech Company Details
        11.11.2 Qingdao Phagepharm Bio-tech Business Overview
        11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction
        11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022)
        11.11.5 Qingdao Phagepharm Bio-tech Recent Developments
    11.12 Fixed-Phage Limited
        11.12.1 Fixed-Phage Limited Company Details
        11.12.2 Fixed-Phage Limited Business Overview
        11.12.3 Fixed-Phage Limited Phage Therapy Introduction
        11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022)
        11.12.5 Fixed-Phage Limited Recent Developments
    11.13 Zeptometrix
        11.13.1 Zeptometrix Company Details
        11.13.2 Zeptometrix Business Overview
        11.13.3 Zeptometrix Phage Therapy Introduction
        11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022)
        11.13.5 Zeptometrix Recent Developments
    11.14 Phage International, Inc.
        11.14.1 Phage International, Inc. Company Details
        11.14.2 Phage International, Inc. Business Overview
        11.14.3 Phage International, Inc. Phage Therapy Introduction
        11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022)
        11.14.5 Phage International, Inc. Recent Developments
    11.15 MicroMir
        11.15.1 MicroMir Company Details
        11.15.2 MicroMir Business Overview
        11.15.3 MicroMir Phage Therapy Introduction
        11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022)
        11.15.5 MicroMir Recent Developments
    11.16 iNtODEWORLD, Inc.
        11.16.1 iNtODEWORLD, Inc. Company Details
        11.16.2 iNtODEWORLD, Inc. Business Overview
        11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction
        11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022)
        11.16.5 iNtODEWORLD, Inc. Recent Developments
    11.17 NEXTBIOTICS
        11.17.1 NEXTBIOTICS Company Details
        11.17.2 NEXTBIOTICS Business Overview
        11.17.3 NEXTBIOTICS Phage Therapy Introduction
        11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022)
        11.17.5 NEXTBIOTICS Recent Developments
    11.18 Armata Pharmaceuticals, Inc.
        11.18.1 Armata Pharmaceuticals, Inc. Company Details
        11.18.2 Armata Pharmaceuticals, Inc. Business Overview
        11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction
        11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022)
        11.18.5 Armata Pharmaceuticals, Inc. Recent Developments
    11.19 Innophage
        11.19.1 Innophage Company Details
        11.19.2 Innophage Business Overview
        11.19.3 Innophage Phage Therapy Introduction
        11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022)
        11.19.5 Innophage Recent Developments
    11.20 Adaptive Phage Therapeutics
        11.20.1 Adaptive Phage Therapeutics Company Details
        11.20.2 Adaptive Phage Therapeutics Business Overview
        11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction
        11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022)
        11.20.5 Adaptive Phage Therapeutics Recent Developments
    11.21 TechnoPhage
        11.21.1 TechnoPhage Company Details
        11.21.2 TechnoPhage Business Overview
        11.21.3 TechnoPhage Phage Therapy Introduction
        11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022)
        11.21.5 TechnoPhage Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer
List of Tables
    Table 1. Global Phage Therapy Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of DsDNA Bacteriophage
    Table 3. Key Players of SsDNA Bacteriophage
    Table 4. Key Players of SsRNA Bacteriophage
    Table 5. Key Players of Others
    Table 6. Global Phage Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 7. Global Phage Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Phage Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Phage Therapy Market Share by Region (2017-2022)
    Table 10. Global Phage Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Phage Therapy Market Share by Region (2023-2028)
    Table 12. Phage Therapy Market Trends
    Table 13. Phage Therapy Market Drivers
    Table 14. Phage Therapy Market Challenges
    Table 15. Phage Therapy Market Restraints
    Table 16. Global Phage Therapy Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Phage Therapy Revenue Share by Players (2017-2022)
    Table 18. Global Top Phage Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2021)
    Table 19. Ranking of Global Top Phage Therapy Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Phage Therapy Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Phage Therapy Product Solution and Service
    Table 23. Date of Enter into Phage Therapy Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Phage Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Phage Therapy Revenue Market Share by Type (2017-2022)
    Table 27. Global Phage Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Phage Therapy Revenue Market Share by Type (2023-2028)
    Table 29. Global Phage Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Phage Therapy Revenue Share by Application (2017-2022)
    Table 31. Global Phage Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Phage Therapy Revenue Share by Application (2023-2028)
    Table 33. North America Phage Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 34. North America Phage Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 35. North America Phage Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 36. North America Phage Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 37. North America Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 38. North America Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Europe Phage Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 40. Europe Phage Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 41. Europe Phage Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 42. Europe Phage Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 43. Europe Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Europe Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Phage Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Phage Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Phage Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Phage Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 49. Asia Pacific Phage Therapy Market Size by Region (2017-2022) & (US$ Million)
    Table 50. Asia Pacific Phage Therapy Market Size by Region (2023-2028) & (US$ Million)
    Table 51. Latin America Phage Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 52. Latin America Phage Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 53. Latin America Phage Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 54. Latin America Phage Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 55. Latin America Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 56. Latin America Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Phage Therapy Market Size by Type (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Phage Therapy Market Size by Type (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Phage Therapy Market Size by Application (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Phage Therapy Market Size by Application (2023-2028) & (US$ Million)
    Table 61. Middle East and Africa Phage Therapy Market Size by Country (2017-2022) & (US$ Million)
    Table 62. Middle East and Africa Phage Therapy Market Size by Country (2023-2028) & (US$ Million)
    Table 63. NPO Microgen Company Details
    Table 64. NPO Microgen Business Overview
    Table 65. NPO Microgen Phage Therapy Product
    Table 66. NPO Microgen Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 67. NPO Microgen Recent Developments
    Table 68. Proteon Pharmaceuticals Company Details
    Table 69. Proteon Pharmaceuticals Business Overview
    Table 70. Proteon Pharmaceuticals Phage Therapy Product
    Table 71. Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 72. Proteon Pharmaceuticals Recent Developments
    Table 73. Phagelux Company Details
    Table 74. Phagelux Business Overview
    Table 75. Phagelux Phage Therapy Product
    Table 76. Phagelux Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 77. Phagelux Recent Developments
    Table 78. Intralytix Company Details
    Table 79. Intralytix Business Overview
    Table 80. Intralytix Phage Therapy Product
    Table 81. Intralytix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 82. Intralytix Recent Developments
    Table 83. Micreos Company Details
    Table 84. Micreos Business Overview
    Table 85. Micreos Phage Therapy Product
    Table 86. Micreos Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 87. Micreos Recent Developments
    Table 88. Eliava BioPreparations Company Details
    Table 89. Eliava BioPreparations Business Overview
    Table 90. Eliava BioPreparations Phage Therapy Product
    Table 91. Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 92. Eliava BioPreparations Recent Developments
    Table 93. Locus Biosciences,Inc Company Details
    Table 94. Locus Biosciences,Inc Business Overview
    Table 95. Locus Biosciences,Inc Phage Therapy Product
    Table 96. Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 97. Locus Biosciences,Inc Recent Developments
    Table 98. Pharmex Group,LLC Company Details
    Table 99. Pharmex Group,LLC Business Overview
    Table 100. Pharmex Group,LLC Phage Therapy Product
    Table 101. Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 102. Pharmex Group,LLC Recent Developments
    Table 103. Pherecydes Pharma Company Details
    Table 104. Pherecydes Pharma Business Overview
    Table 105. Pherecydes Pharma Phage Therapy Product
    Table 106. Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 107. Pherecydes Pharma Recent Developments
    Table 108. APS Biocontrol Ltd. (APS) Company Details
    Table 109. APS Biocontrol Ltd. (APS) Business Overview
    Table 110. APS Biocontrol Ltd. (APS) Phage Therapy Product
    Table 111. APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 112. APS Biocontrol Ltd. (APS) Recent Developments
    Table 113. Qingdao Phagepharm Bio-tech Company Details
    Table 114. Qingdao Phagepharm Bio-tech Business Overview
    Table 115. Qingdao Phagepharm Bio-tech Phage Therapy Product
    Table 116. Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 117. Qingdao Phagepharm Bio-tech Recent Developments
    Table 118. Fixed-Phage Limited Company Details
    Table 119. Fixed-Phage Limited Business Overview
    Table 120. Fixed-Phage Limited Phage Therapy Product
    Table 121. Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 122. Fixed-Phage Limited Recent Developments
    Table 123. Zeptometrix Company Details
    Table 124. Zeptometrix Business Overview
    Table 125. Zeptometrix Phage Therapy Product
    Table 126. Zeptometrix Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 127. Zeptometrix Recent Developments
    Table 128. Phage International, Inc. Company Details
    Table 129. Phage International, Inc. Business Overview
    Table 130. Phage International, Inc. Phage Therapy Product
    Table 131. Phage International, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 132. Phage International, Inc. Recent Developments
    Table 133. MicroMir Company Details
    Table 134. MicroMir Business Overview
    Table 135. MicroMir Phage Therapy Product
    Table 136. MicroMir Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 137. MicroMir Recent Developments
    Table 138. iNtODEWORLD, Inc. Company Details
    Table 139. iNtODEWORLD, Inc. Business Overview
    Table 140. iNtODEWORLD, Inc. Phage Therapy Product
    Table 141. iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 142. iNtODEWORLD, Inc. Recent Developments
    Table 143. NEXTBIOTICS Company Details
    Table 144. NEXTBIOTICS Business Overview
    Table 145. NEXTBIOTICS Phage Therapy Product
    Table 146. NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 147. NEXTBIOTICS Recent Developments
    Table 148. Armata Pharmaceuticals, Inc. Company Details
    Table 149. Armata Pharmaceuticals, Inc. Business Overview
    Table 150. Armata Pharmaceuticals, Inc. Phage Therapy Product
    Table 151. Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 152. Armata Pharmaceuticals, Inc. Recent Developments
    Table 153. Innophage Company Details
    Table 154. Innophage Business Overview
    Table 155. Innophage Phage Therapy Product
    Table 156. Innophage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 157. Innophage Recent Developments
    Table 158. Adaptive Phage Therapeutics Company Details
    Table 159. Adaptive Phage Therapeutics Business Overview
    Table 160. Adaptive Phage Therapeutics Phage Therapy Product
    Table 161. Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 162. Adaptive Phage Therapeutics Recent Developments
    Table 163. TechnoPhage Company Details
    Table 164. TechnoPhage Business Overview
    Table 165. TechnoPhage Phage Therapy Product
    Table 166. TechnoPhage Revenue in Phage Therapy Business (2017-2022) & (US$ Million)
    Table 167. TechnoPhage Recent Developments
    Table 168. Research Programs/Design for This Report
    Table 169. Key Data Information from Secondary Sources
    Table 170. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Phage Therapy Market Share by Type: 2021 VS 2028
    Figure 2. DsDNA Bacteriophage Features
    Figure 3. SsDNA Bacteriophage Features
    Figure 4. SsRNA Bacteriophage Features
    Figure 5. Others Features
    Figure 6. Global Phage Therapy Market Share by Application: 2021 VS 2028
    Figure 7. Animal Health Case Studies
    Figure 8. Aquaculture Case Studies
    Figure 9. Agriculture Case Studies
    Figure 10. Food Industry Case Studies
    Figure 11. Human Health Case Studies
    Figure 12. Others Case Studies
    Figure 13. Phage Therapy Report Years Considered
    Figure 14. Global Phage Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Phage Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Phage Therapy Market Share by Region: 2021 VS 2028
    Figure 17. Global Phage Therapy Market Share by Players in 2021
    Figure 18. Global Top Phage Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phage Therapy as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Phage Therapy Revenue in 2021
    Figure 20. North America Phage Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 21. North America Phage Therapy Market Size Market Share by Type (2017-2028)
    Figure 22. North America Phage Therapy Market Size Market Share by Application (2017-2028)
    Figure 23. North America Phage Therapy Market Size Share by Country (2017-2028)
    Figure 24. United States Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Canada Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Europe Phage Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 27. Europe Phage Therapy Market Size Market Share by Type (2017-2028)
    Figure 28. Europe Phage Therapy Market Size Market Share by Application (2017-2028)
    Figure 29. Europe Phage Therapy Market Size Share by Country (2017-2028)
    Figure 30. Germany Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. France Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. U.K. Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Italy Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Russia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Nordic Countries Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Phage Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 37. Asia Pacific Phage Therapy Market Size Market Share by Type (2017-2028)
    Figure 38. Asia Pacific Phage Therapy Market Size Market Share by Application (2017-2028)
    Figure 39. Asia Pacific Phage Therapy Market Size Share by Region (2017-2028)
    Figure 40. China Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Japan Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. South Korea Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Southeast Asia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. India Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Australia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Latin America Phage Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 47. Latin America Phage Therapy Market Size Market Share by Type (2017-2028)
    Figure 48. Latin America Phage Therapy Market Size Market Share by Application (2017-2028)
    Figure 49. Latin America Phage Therapy Market Size Share by Country (2017-2028)
    Figure 50. Mexico Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 51. Brazil Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Phage Therapy Market Size YoY (2017-2028) & (US$ Million)
    Figure 53. Middle East and Africa Phage Therapy Market Size Market Share by Type (2017-2028)
    Figure 54. Middle East and Africa Phage Therapy Market Size Market Share by Application (2017-2028)
    Figure 55. Middle East and Africa Phage Therapy Market Size Share by Country (2017-2028)
    Figure 56. Turkey Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 57. Saudi Arabia Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 58. UAE Phage Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 59. NPO Microgen Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 60. Proteon Pharmaceuticals Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 61. Phagelux Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 62. Intralytix Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 63. Micreos Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 64. Eliava BioPreparations Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 65. Locus Biosciences,Inc Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 66. Pharmex Group,LLC Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 67. Pherecydes Pharma Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 68. APS Biocontrol Ltd. (APS) Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 69. Qingdao Phagepharm Bio-tech Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 70. Fixed-Phage Limited Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 71. Zeptometrix Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 72. Phage International, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 73. MicroMir Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 74. iNtODEWORLD, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 75. NEXTBIOTICS Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 76. Armata Pharmaceuticals, Inc. Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 77. Innophage Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 78. Adaptive Phage Therapeutics Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 79. TechnoPhage Revenue Growth Rate in Phage Therapy Business (2017-2022)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
NPO Microgen
Proteon Pharmaceuticals
Phagelux
Intralytix
Micreos
Eliava BioPreparations
Locus Biosciences,Inc
Pharmex Group,LLC
Pherecydes Pharma
APS Biocontrol Ltd. (APS)
Qingdao Phagepharm Bio-tech
Fixed-Phage Limited
Zeptometrix
Phage International, Inc.
MicroMir
iNtODEWORLD, Inc.
NEXTBIOTICS
Armata Pharmaceuticals, Inc.
Innophage
Adaptive Phage Therapeutics
TechnoPhage
Frequently Asked Questions
Phage Therapy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Phage Therapy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Phage Therapy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Motorcycle Racing

Motorcycle Racing market is segmented by players, region (country), by Type and by Application. P ... Read More

Cosmetic Retinol

Cosmetic Retinol market is segmented by Type and by Application. Players, stakeholders, and other ... Read More